J
Joe B. Putnam
Researcher at University of Texas MD Anderson Cancer Center
Publications - 223
Citations - 18691
Joe B. Putnam is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lung cancer & Survival rate. The author has an hindex of 71, co-authored 222 publications receiving 17600 citations. Previous affiliations of Joe B. Putnam include Kobe University & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
Jack A. Roth,Frank V. Fossella,Ritsuko Komaki,M.Bernadette Ryan,Joe B. Putnam,Jin Soo Lee,Hari M. Dhingra,Louis De Caro,Marvin H. Chasen,Malcoln Mcgavran,E. Neely Atkinson,Waun Ki Hong +11 more
TL;DR: This clinical trial strengthens the validity of using perioperative chemotherapy in the management of patients with resectable stage IIIA non-small-cell lung cancer by suggesting that survival is improved when compared with treatment by surgery alone.
Journal ArticleDOI
Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer.
Jack A. Roth,Duyen Thi Cam Nguyen,David D. Lawrence,Bonnie L. Kemp,Cesar H. Carrasco,D. Z. Ferson,Waun Ki Hong,R.U. Komaki,J. Jack Lee,Jonathan C. Nesbitt,Katherine M.W. Pisters,Joe B. Putnam,R. Schea,Dong M. Shin,G. L. Walsh,Marcelo Dolormente,C. I. Han,Faye Martin,Nancy Yen,Kai Xu,L. C. Stephens,Timothy J. McDonnell,Tapas Mukhopadhyay,De Wei Cai +23 more
TL;DR: A retroviral vector containing the wild-type p53 gene under control of a beta-actin promoter was produced to mediate transfer of wild type p53 into human non-small cell lung cancers by direct injection as mentioned in this paper.
Journal ArticleDOI
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial
Gail Darling,Mark S. Allen,Paul A. Decker,Karla V. Ballman,Richard A. Malthaner,Richard Inculet,David R. Jones,Robert McKenna,Rodney J. Landreneau,Valerie W. Rusch,Joe B. Putnam +10 more
TL;DR: If systematic and thorough presection sampling of the mediastsinal and hilar lymph nodes is negative, mediastinal lymph node dissection does not improve survival in patients with early stage non-small cell lung cancer, but these results are not generalizable to patients staged radiographically or those with higher stage tumors.
Journal ArticleDOI
Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial
Mark S. Allen,Gail E. Darling,Taine T.V. Pechet,John D. Mitchell,James E. Herndon,Rodney J. Landreneau,Richard Inculet,David R. Jones,Bryan F. Meyers,David H. Harpole,Joe B. Putnam,Valerie W. Rusch +11 more
TL;DR: Complete mediastinal lymphadenectomy adds little morbidity to a pulmonary resection for lung cancer, and a new baseline with which to compare results in the future is established.
Journal ArticleDOI
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
Stephen G. Swisher,Jack A. Roth,John Nemunaitis,David D. Lawrence,Bonnie L. Kemp,Cesar H. Carrasco,Dee G. Connors,Adel K. El-Naggar,Frank V. Fossella,Bonnie S. Glisson,Waun Ki Hong,Fadlo R. Khuri,Jonathan M. Kurie,Jack Lee,Jin S. Lee,Michael J. Mack,James A. Merritt,Dao M. Nguyen,Jonathan C. Nesbitt,Roman Perez-Soler,Katherine M.W. Pisters,Joe B. Putnam,W. R. Richli,Michael Savin,David S. Schrump,Dong M. Shin,Allan Shulkin,Garrett L. Walsh,Juliette Wait,David Weill,M. Kimberly A. Waugh +30 more
TL;DR: Repeated intratumoral injections of Ad-p53 appear to be well tolerated, result in transgene expression of wild-type p53, and seem to mediate antitumor activity in a subset of patients with advanced NSCLC.